Colon Cancer Treatment - Erbitux Less Effective For Colon Cancer Patients With Second Gene - Eflux Media
Erbitux Less Effective For Colon Cancer Patients With Second Gene - Eflux Media
Treatment with cetuximab (Erbitux) was less effective for patients with advanced colorectal cancer with a certain gene mutation, a new study found. Scientists already knew that the presence of K-ras mutations explains about 30 to 40 percent of cases
Colon Cancer Drug Won’t Help Those With Certain Gene Mutation - National Womens Health Information Center
WEDNESDAY, Oct. 22 (HealthDay News) — A new study suggests that people with advanced colon cancer who have a particular gene mutation won’t benefit from the medication cetuximab (Erbitux). While the drug can add months to the lives of people without
Cancer center honors TV anchor Robin Roberts - Forbes
Robin Roberts has been honored in New York for sharing her cancer treatment experience with millions of television viewers. ABC’s “Good Morning America” co-anchor accepted the 2008 Roswell Park Cancer Institute’s Gilda Radner Courage Award on
Beating the odds against cancer - Saratogian
Karen Bjornland Desjardins poses as Miss December in The Colon Club s 2009 Colondar, a calendar designed to educate people about colorectal cancer. Sales of the 2009 Colondar will help The Colon Club continue to produce more projects to raise